Seizert Capital Partners’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-291,346
Closed -$3.69M 189
2023
Q4
$3.69M Buy
291,346
+38,980
+15% +$492K 0.19% 79
2023
Q3
$3.44M Buy
252,366
+7,482
+3% +$116K 0.18% 86
2023
Q2
$4.2M Sell
244,884
-13,976
-5% -$217K 0.23% 72
2023
Q1
$3.61M Sell
258,860
-44,156
-15% -$650K 0.2% 83
2022
Q4
$4.05M Sell
303,016
-26,808
-8% -$347K 0.22% 77
2022
Q3
$3.93M Hold
329,824
0.22% 78
2022
Q2
$4.2M Sell
329,824
-438
-0.1% -$5.62K 0.22% 73
2022
Q1
$4.27M Buy
330,262
+84,659
+34% +$1.12M 0.2% 80
2021
Q4
$3.89M Buy
245,603
+5,988
+2% +$102K 0.17% 92
2021
Q3
$4.67M Buy
239,615
+17,309
+8% +$344K 0.21% 71
2021
Q2
$5.06M Buy
222,306
+31,591
+17% +$656K 0.24% 71
2021
Q1
$3.5M Buy
190,715
+68,078
+56% +$1.12M 0.18% 77
2020
Q4
$1.83M Buy
+122,637
New +$1.6M 0.11% 91

Other funds holding SEM

Seizert Capital Partners's SEM Position: Q1 2024 in Review

Seizert Capital Partners sold out of Select Medical (SEM) in Q1 2024, closing a stake of 291,346 shares — an estimated $3.69M sold.

Seizert Capital Partners first reported a position in SEM in Q4 2020 and held it in 13 quarters. The position peaked at $5.06M in Q2 2021. 250 funds tracked by Wall St. Rank hold SEM as of Q1 2024.

  • Seizert Capital Partners reported no remaining Select Medical position as of Q1 2024 after selling out during the quarter.
  • Seizert Capital Partners sold 291,346 Select Medical shares in Q1 2024, an estimated $3.69M.
  • Seizert Capital Partners first reported a position in Select Medical in Q4 2020 and held it in 13 quarters.
  • Seizert Capital Partners's Select Medical position peaked at $5.06M in Q2 2021.
  • 250 funds tracked by Wall St. Rank held Select Medical as of Q1 2024.

Based on Seizert Capital Partners's 13F filing for Q1 2024, filed 1 May 2024.